Eli Lilly Earnings Miss, Covid-19 Treatment Fails In Trials
- Oops!Something went wrong.Please try again later.
Eli Lilly early Tuesday posted third-quarter earnings and sales that missed Wall Street expectations and said that one of its Covid-19 treatments failed in clinical trials; LLY stock fell.